Literature DB >> 15613066

Predictive cardiovascular risk factors in patients with chronic kidney disease (CKD).

Marian Goicoechea1, Soledad García de Vinuesa, Francisco Gómez-Campderá, José Luño.   

Abstract

BACKGROUND: Traditional cardiovascular risk factors and uremia-related specific factors have been identified in patients with CKD, explaining the highest risk for morbidity and mortality from cardiovascular disease. The aim of this study was to analyze the predictive power of several cardiovascular risk factors and markers in a population of stable patients with moderate CKD.
METHODS: One hundred twenty-eight (78 M, 50 F) outpatients with estimated glomerular filtration rate (GFR) <60 mL/min were included in the study. Medical records about cardiovascular factors were recorded. Analytical parameters and cardiac markers were analyzed. The patients were prospectively followed, and the end points were fatal and nonfatal cardiovascular events.
RESULTS: After a mean follow-up of 22.3 months, 27 patients had a cardiovascular event. The patients who suffered a cardiovascular event were older (P= 0.002), with more anemia (P= 0.014), higher pulse pressure (P= 0.011), and cTnT levels (P= 0.000). In addition, they had more prevalence of LVH (P= 0.001), diabetes (P= 0.013), previous coronary heart disease (P= 0.008), chronic heart failure (P= 0.000), vascular peripheral disease (P= 0.006), and had also a higher score of 10-year coronary heart disease predicted risk (P= 0.006). Age [hazard ratio (HR) 1.07, P= 0.02], previous coronary artery disease (HR 4.08, P= 0.0012), and cTnT levels (HR 1.64, P= 0.0000) independently predicted cardiovascular events on multivariate Cox analysis.
CONCLUSION: In stable patients with CKD, age and previous coronary artery disease were the traditional cardiovascular risk factors more predictive for cardiovascular events. Cardiac troponin T is a powerful marker of cardiovascular events in CKD patients.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15613066     DOI: 10.1111/j.1523-1755.2005.09308.x

Source DB:  PubMed          Journal:  Kidney Int Suppl        ISSN: 0098-6577            Impact factor:   10.545


  27 in total

1.  Anemia treatment with Q2W darbepoetin alfa in patients with chronic kidney disease naïve to erythropoiesis-stimulating agents.

Authors:  M R Silver; R Geronemus; M Krause; C Y Chen; R Kewalramani; C Stehman-Breen
Journal:  Curr Med Res Opin       Date:  2009-01       Impact factor: 2.580

2.  Timing of erythropoiesis-stimulating agent initiation and adverse outcomes in nondialysis CKD: a propensity-matched observational study.

Authors:  Stephen Seliger; Kathleen M Fox; Shravanthi R Gandra; Brian Bradbury; Van Doren Hsu; Loreen Walker; Chiun-Fang Chiou; Jeffrey C Fink
Journal:  Clin J Am Soc Nephrol       Date:  2010-03-18       Impact factor: 8.237

3.  Alteration of cardiovascular structure and function in patients undergoing peritoneal dialysis.

Authors:  Damir R Rebić; Senija R Rašić; Muamer D Dervišević; Aida H M Hamzić-Mehmedbašić; Alma M Muslimović; Edina H Hasanagić
Journal:  Cardiorenal Med       Date:  2015-03-25       Impact factor: 2.041

Review 4.  Addressing the global burden of chronic kidney disease through clinical and translational research.

Authors:  Akinlolu Ojo
Journal:  Trans Am Clin Climatol Assoc       Date:  2014

5.  Coronary artery calcifications in children with end-stage renal disease.

Authors:  Mahmut Civilibal; Salim Caliskan; Ibrahim Adaletli; Huseyin Oflaz; Lale Sever; Cengiz Candan; Nur Canpolat; Ozgur Kasapcopur; Sebuh Kuruoglu; Nil Arisoy
Journal:  Pediatr Nephrol       Date:  2006-07-04       Impact factor: 3.714

6.  Carotid intima media thickness, oxidative stress, and inflammation in children with chronic kidney disease.

Authors:  Juan Antonio Garcia-Bello; Rita A Gómez-Díaz; Alicia Contreras-Rodríguez; Juan O Talavera; Rafael Mondragón-González; Lorena Sanchez-Barbosa; Margarita Diaz-Flores; Adan Valladares-Salgado; Juan Manuel Gallardo; Alejandra Aguilar-Kitsu; Jesus Lagunas-Munoz; Niels H Wacher
Journal:  Pediatr Nephrol       Date:  2014-02       Impact factor: 3.714

7.  Erythropoiesis-stimulating agents increase the risk of acute stroke in patients with chronic kidney disease.

Authors:  Stephen L Seliger; Amy D Zhang; Matthew R Weir; Loreen Walker; Van Doren Hsu; Afshin Parsa; Clarissa J Diamantidis; Jeffrey C Fink
Journal:  Kidney Int       Date:  2011-03-09       Impact factor: 10.612

8.  Left ventricular systolic and diastolic function and carotid intima-media thickness in pediatric dialysis patients.

Authors:  Mahmut Civilibal; Huseyin Oflaz; Salim Caliskan; Cengiz Candan; Nur Canpolat; Gulseren Pehlivan; Lale Sever; Ozgur Kasapcopur; Nil Arisoy
Journal:  Int Urol Nephrol       Date:  2008-08-09       Impact factor: 2.370

9.  Decreased circulating klotho levels in patients undergoing dialysis and relationship to oxidative stress and inflammation.

Authors:  Hyung Jung Oh; Bo Young Nam; Mi Jung Lee; Chan Ho Kim; Hyang Mo Koo; Fa Mee Doh; Jae Hyun Han; Eun Jin Kim; Ji Suk Han; Jung Tak Park; Tae-Hyun Yoo; Shin-Wook Kang; Dae-Suk Han; Seung Hyeok Han
Journal:  Perit Dial Int       Date:  2014-02-04       Impact factor: 1.756

10.  Waist circumference is associated with carotid intima media thickness in peritoneal dialysis patients.

Authors:  Ebru Asicioglu; Arzu Kahveci; Hakkı Arikan; Mehmet Koc; Serhan Tuglular; Cetin Ishak Ozener
Journal:  Int Urol Nephrol       Date:  2013-04-04       Impact factor: 2.370

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.